CAN-202

N/A

Report date: 2023/10/26 16:55:56

Base Information

Drug NameCAN-202
Drug Alias NameCAN-202
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGAA gene transference
TargetsAcidic alpha-glucosidase
Therapy Area/IndicationsGlycogen Storage Disease Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeihai Kangcheng (Beijing) Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeihai Kangcheng (Beijing) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A